MELLARIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mellaril, and when can generic versions of Mellaril launch?
Mellaril is a drug marketed by Novartis and is included in two NDAs.
The generic ingredient in MELLARIL is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MELLARIL?
- What are the global sales for MELLARIL?
- What is Average Wholesale Price for MELLARIL?
Summary for MELLARIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,222 |
| DailyMed Link: | MELLARIL at DailyMed |
Recent Clinical Trials for MELLARIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oxnard Foundation | Early Phase 1 |
| New Mexico Cancer Care Alliance | Early Phase 1 |
US Patents and Regulatory Information for MELLARIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | MELLARIL | thioridazine hydrochloride | CONCENTRATE;ORAL | 011808-012 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-009 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-016 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-017 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | CONCENTRATE;ORAL | 011808-018 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | MELLARIL | thioridazine hydrochloride | TABLET;ORAL | 011808-011 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
